La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (metabolism) < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology) < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (therapeutic use)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000072 (1999) C. Fillebeen [France] ; V. Mitchell ; D. Dexter ; M. Benaissa ; J. Beauvillain ; G. Spik ; A. PierceLactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment.
000079 (1999) E. Bezard [France] ; C. Brefel ; F. Tison ; H. Peyro-Saint-Paul ; P. Ladure ; O. Rascol ; C E GrossEffect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey.
000089 (2000) Andreas Hartmann [France] ; Stéphane Hunot [France] ; Patrick P. Michel [France] ; Marie-Paule Muriel [France] ; Sheela Vyas [Royaume-Uni] ; Baptiste A. Faucheux [France] ; Annick Mouatt-Prigent [France] ; Hélène Turmel [France] ; Anu Srinivasan [États-Unis] ; Merle Ruberg [France] ; Gerard I. Evan [Royaume-Uni] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
000477 (2004) John Mitrofanis [France] ; Keyoumars Ashkan ; Bradley A. Wallace ; Alim-Louis BenabidChemoarchitectonic heterogeneities in the primate zona incerta: clinical and functional implications.
000814 (2008) Camille Brochier [France] ; Marie-Claude Gaillard ; Elsa Diguet ; Nicolas Caudy ; Carole Dossat ; Béatrice Ségurens ; Patrick Wincker ; Emmanuel Roze ; Jocelyne Caboche ; Philippe Hantraye ; Emmanuel Brouillet ; Jean-Marc Elalouf ; Michel De ChaldéeQuantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models.
001049 (2013) Romina Aron Badin [France] ; Brigitte Spinnewyn [France] ; Marie-Claude Gaillard [France] ; Caroline Jan [France] ; Carole Malgorn [France] ; Nadja Van Camp [France] ; Frédéric Dollé [France] ; Martine Guillermier [France] ; Sabrina Boulet [France] ; Anne Bertrand [France] ; Marc Savasta [France] ; Michel Auguet [France] ; Emmanuel Brouillet [France] ; Pierre-Etienne Chabrier [France] ; Philippe Hantraye [France]IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates
001418 (2014) Carmen Noelker [France, Allemagne] ; Lydie Morel [France] ; Anke Osterloh [Allemagne] ; Daniel Alvarez-Fischer [France, Allemagne] ; Thomas Lescot [France] ; Minka Breloer [Allemagne] ; Maike Gold [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Carmen Henze [France] ; Patrick P. Michel [France] ; Richard C. Dodel [Allemagne] ; Lixia Lu [France] ; Etienne C. Hirsch [France] ; Stéphane Hunot [France] ; Andreas Hartmann [France]Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease
001741 (2015) Hyung-Wook Kim [États-Unis, Corée du Sud] ; Won-Seok Choi [États-Unis, Corée du Sud] ; Noah Sorscher [États-Unis] ; Hyung Joon Park [Corée du Sud] ; François Tronche [France] ; Richard D. Palmiter [États-Unis] ; Zhengui Xia [États-Unis]Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo
001755 (2015) Carmen Noelker [Allemagne] ; Lixia Lu [France] ; Matthias Höllerhage [Allemagne] ; Franca Vulinovic [Allemagne] ; Annekathrin Sturn [Allemagne] ; René Roscher [Suisse] ; Günter U. Höglinger [Allemagne] ; Etienne C. Hirsch [France] ; Wolfgang H. Oertel [Allemagne] ; Daniel Alvarez-Fischer [Allemagne] ; Hartmann Andreas [France]Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease.
001843 (2016) Fannie Darlot [France] ; Cécile Moro [France] ; Nabil El Massri [Australie] ; Claude Chabrol [France] ; Daniel M. Johnstone [Australie] ; Florian Reinhart [France] ; Diane Agay [France] ; Napoleon Torres [France] ; Dhaïf Bekha [France] ; Vincent Auboiroux [France] ; Thomas Costecalde [France] ; Cassandra L. Peoples [Australie] ; Helena D T. Anastascio [Australie] ; Victoria E. Shaw [Australie] ; Jonathan Stone [Australie] ; John Mitrofanis [Australie] ; Alim-Louis Benabid [France]Near-infrared light is neuroprotective in a monkey model of Parkinson disease.
001880 (2016) Sandra Dovero [France] ; Christian Gross [France] ; Erwan Bezard [France]Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of Parkinson's disease?
001928 (2016) Thibaud Thiollier [France] ; Caisheng Wu ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang ; Erwan Bezard [France]Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.
001A25 (2016) Samuela Cataldi [Italie] ; Michela Codini [Italie] ; Stéphane Hunot [France] ; François-Pierre Légeron [France] ; Ivana Ferri [Italie] ; Paola Siccu [Italie] ; Angelo Sidoni [Italie] ; Francesco Saverio Ambesi-Impiombato [Italie] ; Tommaso Beccari [Italie] ; Francesco Curcio [Italie] ; Elisabetta Albi [Italie]e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease
001C73 (1994) A. Boireau [France] ; P. Dubédat ; F. Bordier ; C. Peny ; J M Miquet ; G. Durand ; M. Meunier ; A. DobleRiluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.
001C97 (1993) M T Herrero [France] ; E C Hirsch ; F. Javoy-Agid ; J A Obeso ; Yves Agid [France]Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum.
001E26 (1995) E. Brouillet [France] ; P. HantrayeEffects of chronic MPTP and 3-nitropropionic acid in nonhuman primates.
001E32 (1996) T. Boraud [France] ; E. Bezard ; B. Bioulac ; C. GrossHigh frequency stimulation of the internal Globus Pallidus (GPi) simultaneously improves parkinsonian symptoms and reduces the firing frequency of GPi neurons in the MPTP-treated monkey.
001E55 (1997) E. Bezard [France] ; T. Boraud ; B. Bioulac ; C E GrossPresymptomatic revelation of experimental parkinsonism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024